Premium Reports
Contact KLAS
 Download Report    Zoom in charts



Related Series

Bluesight Insights

 End chart zoom
Bluesight CostCheck (formerly Kit Check Bluesight Insights) 2023 Bluesight CostCheck (formerly Kit Check Bluesight Insights) 2023
* A page refresh may be necessary to see the updated image

Bluesight CostCheck (formerly Kit Check Bluesight Insights) 2023
Actionable Insights to Reduce Medication Spend

author - Jackson Tate
Jackson Tate
author - Kyle Chilton
Kyle Chilton
January 20, 2023 | Read Time: 1  minute

The Bluesight CostCheck solution (formerly Kit Check Bluesight Insights) assists hospitals and health systems with making intelligent buying decisions by providing real-time market insights. KLAS reported on the product in May 2021, when it was Bluesight Insights and there were six unique customers live. The vendor has expanded the product to 44 fully live facilities at 15 unique organization and implemented several upgrades, including improved reporting and prioritized recommendations. This report provides a second look at how the CostCheck customer experience is progressing through the solution’s growth and changes.

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.

Key Findings:

  1. Bluesight CostCheck Customer Experience: An Initial Look
  2. Points to Ponder
  3. Bluesight: Company Profile at a Glance
  4. Solution Technical Specifications (provided by Bluesight)
author - Madison Moniz
Madison Moniz
author - Robert Ellis
Project Manager
Robert Ellis
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.